Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▴	Revenue growth	Diluted EPS
SLS	SELLAS Life Sciences Group, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.86M	n/a	-37.9%	n/a	-$0.25
CURX	Curanex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$4.23M	n/a	-37.7%	n/a	-$0.17
CLYM	Climb Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.85M	n/a	-37.3%	n/a	-$0.88
KTTA	Pasithea Therapeutics Corp. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.43M	n/a	-37.0%	n/a	-$2.91
GERN	Geron Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$83.50M	n/a	-37.0%	n/a	-$0.13
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
XBIO	Xenetic Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.98M	-$2.68M	-90.1%	-36.2%	19.0%	-$1.58
BCYC	Bicycle Therapeutics PLC Manufacturing · Year ended 2025-12-31 · USD	$72.59M	-$218.96M	-301.7%	-35.9%	105.8%	-$3.16
DERM	Journey Medical Corp Manufacturing · Year ended 2025-12-31 · USD	$61.24M	-$11.43M	-18.7%	-35.9%	11.1%	-$0.47
ANAB	Anaptysbio, Inc Manufacturing · Year ended 2025-12-31 · USD	$234.60M	-$13.23M	-5.6%	-35.6%	157.0%	-$0.46
MPLT	MapLight Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$161.15M	n/a	-35.2%	n/a	-$18.56
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
PRAX	Praxis Precision Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$303.27M	n/a	-34.5%	-100.0%	-$13.48
BCAX	Bicara Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$137.95M	n/a	-34.4%	n/a	-$2.52
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
NGNE	Neurogene Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$90.35M	n/a	-34.1%	-100.0%	-$4.24
OLMA	Olema Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$162.45M	n/a	-33.9%	n/a	-$1.87
ORIC	Oric Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$129.47M	n/a	-33.7%	n/a	-$1.47
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
IMNM	Immunome Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.94M	-$212.39M	n/m	-33.5%	-23.2%	-$2.43
NKTX	Nkarta, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$104.08M	n/a	-33.3%	n/a	-$1.41
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
DSGN	Design Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$69.79M	n/a	-32.8%	n/a	-$1.22
BBOT	BridgeBio Oncology Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$134.04M	n/a	-32.6%	n/a	-$4.30
XBIT	XBiotech Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.54M	n/a	-32.4%	n/a	-$1.49

Rows per page: 2550 100